予測診断の世界市場

予測診断の世界市場は2030年までに53億米ドルに達する見込み

2023年に26億米ドルと推定される予測診断の世界市場は、2023年から2030年にかけてCAGR 10.4%で成長し、2030年には53億米ドルに達すると予測されます。

米国市場は7億3,530万米ドルと推定、中国はCAGR 9.7％で成長予測

米国の予測診断市場は、2023年に7億3,530万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 9.7%で推移し、2030年までに8億480万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.3%と8.6%と予測されています。欧州では、ドイツがCAGR約8.4%で成長すると予測されています。

世界の予測診断市場- 主要動向と促進要因のまとめ

予防ヘルスケアは、より深刻な状態に発展する前に健康リスクを管理するため、早期発見と予防に重点を置いた、反応的医療から予防的医療への転換を経験しています。このプロアクティブなアプローチには、定期的な検診、予防接種、教育普及活動が含まれ、より健康な人口の育成を目的としています。特に予防検診は、早期に警告を発し、深刻な健康被害を防ぐ、現代ヘルスケアに不可欠なものとなっています。たとえばインドでは、特にII型糖尿病のような、早期発見によって心不全などの合併症を防ぐことができる疾患について、在宅診断検査の人気が急上昇しています。同様に、子宮頸がんのHPV検査や乳がんの定期検診など、早期のがん検診は生存率を大幅に向上させています。こうした予防措置は、健康状態の改善につながるだけでなく、大がかりな治療や入院の必要性を最小限に抑えることで、経済的負担も軽減します。

技術の進歩は、予防医療をより効率的で広範なものにしつつあります。人工知能（AI）と機械学習（ML）は診断精度を高め、心臓病やアルツハイマー病などの病気の早期発見を可能にしています。FDA（米国食品医薬品局）は、AIベースの診断ツールのがん識別の精度を高く評価しており、特に資源が限られた環境におけるヘルスケア提供を改善する可能性を浮き彫りにしています。さらに、ヘルスケア組織は、MLと高度なアナリティクスを活用して業務効率と患者ケアを強化する洞察を引き出す予測分析を通じて、膨大なデータプールを活用するようになってきています。このアプローチは疾病の予防と管理に役立ち、疾病の進行を予測し早期介入を促進することで患者の転帰を改善します。モノのインターネット（IoT）技術は、患者の健康状態をリアルタイムで監視し、病状の悪化を防ぐタイムリーな医療介入を可能にすることで、これをさらに強化します。

このような利点があるにもかかわらず、予測診断と早期発見技術の採用は、需要の確立、利点に関する患者の教育、これらの技術革新に対する財政的・規制的支援の確保といった課題に直面しています。これらの障害に対処するために、ヘルスケア組織は徹底した市場調査を行い、戦略的パートナーシップを形成し、研究開発に投資する必要があります。予防ヘルスケアの範囲を広げるためには、知的財産の保護と、新技術を既存のヘルスケアシステムに組み込むことも不可欠です。予測診断の広範な導入は、予防と早期介入に焦点を当てたヘルスケアの大変革を告げるものです。このアプローチは、ヘルスケアコストの削減を目指すだけでなく、生活の質を高め、世界のヘルスケアシステムにおけるレジリエントな未来への礎となります。

調査対象企業の例（全47件）

• Abbott Molecular
• Almac Group Ltd.
• Ambry Genetics Corp.
• BioGenex
• Epistem Ltd.
• Epistem Ltd.
• MDxHEALTH Inc.
• Myriad Genetics Inc.
• OPKO Health, Inc.
• Prometheus Laboratories Inc.
• QIAGEN N.V.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

Global Predictive Diagnostics Market to Reach US$5.3 Billion by 2030

The global market for Predictive Diagnostics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$735.3 Million While China is Forecast to Grow at 9.7% CAGR

The Predictive Diagnostics market in the U.S. is estimated at US$735.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$804.8 Million by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Predictive Diagnostics Market - Key Trends and Drivers Summarized

Preventive healthcare is experiencing a transformative shift from reactive to proactive medical practices, emphasizing early detection and prevention to manage health risks before they develop into more severe conditions. This proactive approach includes regular screenings, vaccinations, and educational outreach, aimed at fostering a healthier population. Preventive screenings, in particular, have become an integral part of modern healthcare, offering early warnings and preventing serious health outcomes. For instance, in India, the popularity of home-diagnostic tests is surging, particularly for conditions like Type II diabetes where early detection can prevent complications such as heart failure. Similarly, early cancer screenings, like HPV tests for cervical cancer and routine checks for breast cancer, have significantly improved survival rates. These preventive measures not only lead to better health outcomes but also reduce the economic burden by minimizing the need for extensive treatments and hospitalizations.

Technological advancements are making preventive care more efficient and widespread. Artificial intelligence (AI) and machine learning (ML) are enhancing diagnostic accuracy, enabling earlier detection of diseases such as heart conditions and Alzheimer’s. The FDA has recognized AI-based diagnostic tools for their precision in identifying cancer, which highlights their potential to improve healthcare delivery, especially in resource-limited environments. Additionally, healthcare organizations are increasingly leveraging vast data pools through predictive analytics, which utilizes ML and advanced analytics to extract insights that enhance operational efficiency and patient care. This approach helps in disease prevention and management, improving patient outcomes by predicting disease progression and facilitating early intervention. The Internet of Things (IoT) technology further augments this by allowing real-time monitoring of patient health, enabling timely medical interventions that prevent conditions from worsening, thus reducing hospital visits and enhancing overall patient outcomes.

Despite the benefits, the adoption of predictive diagnostics and early detection technologies faces challenges such as establishing demand, educating patients on the benefits, and securing financial and regulatory support for these innovations. To address these obstacles, healthcare organizations need to conduct thorough market research, form strategic partnerships, and invest in research and development. Protecting intellectual property and integrating new technologies into existing healthcare systems are also vital for expanding the scope of preventive healthcare. The broader adoption of predictive diagnostics heralds a major transformation in healthcare, focusing on prevention and early intervention. This approach not only aims to reduce healthcare costs but also enhances the quality of life, setting a foundation for a resilient future in global healthcare systems.

Select Competitors (Total 47 Featured) -

• Abbott Molecular
• Almac Group Ltd.
• Ambry Genetics Corp.
• BioGenex
• Epistem Ltd.
• Epistem Ltd.
• MDxHEALTH Inc.
• Myriad Genetics Inc.
• OPKO Health, Inc.
• Prometheus Laboratories Inc.
• QIAGEN N.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Predictive Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in AI and Machine Learning Propel Growth in Predictive Diagnostics
  • Increasing Healthcare Data Availability Expands Addressable Market Opportunity
  • Rising Incidence of Chronic Diseases Throws the Spotlight on Predictive Diagnostics
  • Growing Emphasis on Preventive Healthcare Generates Demand for Predictive Solutions
  • Integration with Electronic Health Records (EHR) Spurs Adoption
  • Personalized Medicine Trends Sustain Growth in Predictive Diagnostic Tools
  • Big Data Analytics Advances Propel Growth in Predictive Healthcare Solutions
  • Cloud Computing Innovations Expand Addressable Market for Predictive Diagnostics
  • Improved Patient Outcomes through Early Detection Strengthens Business Case for Predictive Diagnostics
  • AI-driven Predictive Models Generate Demand for Advanced Diagnostic Tools
  • Real-time Monitoring and Predictive Analytics Propel Growth in Patient Care Management
  • Innovations in Biomarker Discovery Generate Opportunities for Predictive Diagnostics
  • Integration with IoT Devices in Healthcare Propels Growth of Predictive Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Predictive Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Predictive Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 5: USA Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 6: USA Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• CANADA
  • TABLE 7: Canada Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 8: Canada Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• JAPAN
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 9: Japan Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 10: Japan Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• CHINA
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 11: China Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 12: China Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• EUROPE
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 13: Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 14: Europe Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • TABLE 15: Europe 16-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
• FRANCE
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 16: France Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: France Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• GERMANY
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 18: Germany Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Germany Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• ITALY
  • TABLE 20: Italy Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Italy Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• UNITED KINGDOM
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 22: UK Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: UK Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• REST OF EUROPE
  • TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: Rest of Europe Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• ASIA-PACIFIC
  • Predictive Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Asia-Pacific Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
• REST OF WORLD
  • TABLE 28: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics by Segment - Predictive Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Rest of World Historic Review for Predictive Diagnostics by Segment - Predictive Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION